76 related articles for article (PubMed ID: 24023320)
1. Vitamin D favorably alters the cancer promoting prostaglandin cascade.
Qin W; Smith C; Jensen M; Holick MF; Sauter ER
Anticancer Res; 2013 Sep; 33(9):3861-6. PubMed ID: 24023320
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 Treatment Influences PGE2 and TGFβ in Normal and Increased Breast Cancer Risk Women.
Qin W; Holick MF; Sorensen W; Walker CR; Sauter ER
Anticancer Res; 2016 Oct; 36(10):5347-5353. PubMed ID: 27798898
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer.
Sauter ER; Qin W; Schlatter L; Hewett JE; Flynn JT
BMC Cancer; 2006 Oct; 6():248. PubMed ID: 17049084
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of celecoxib on prostaglandin E2 concentrations in nipple aspirate fluid from women at increased risk of breast cancer.
Sauter ER; Schlatter L; Hewett J; Koivunen D; Flynn JT
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1745-50. PubMed ID: 15533902
[TBL] [Abstract][Full Text] [Related]
5. uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.
Qin W; Zhu W; Hewett JE; Rottinghaus G; Chen YC; Flynn JT; Kliethermes B; Mannello F; Sauter ER
BMC Cancer; 2008 Oct; 8():298. PubMed ID: 18922176
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women.
Sauter ER; Qin W; Hewett JE; Ruhlen RL; Flynn JT; Rottinghaus G; Chen YC
BMC Cancer; 2008 Feb; 8():49. PubMed ID: 18267025
[TBL] [Abstract][Full Text] [Related]
7. The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland.
Mazahery H; Stonehouse W; von Hurst PR
Eur J Clin Nutr; 2015 Mar; 69(3):367-72. PubMed ID: 25491499
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts.
Liu X; Nelson A; Wang X; Farid M; Gunji Y; Ikari J; Iwasawa S; Basma H; Feghali-Bostwick C; Rennard SI
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):40-50. PubMed ID: 23941558
[TBL] [Abstract][Full Text] [Related]
9. Impact of high-dose vitamin D
Han JE; Alvarez JA; Jones JL; Tangpricha V; Brown MA; Hao L; Brown LAS; Martin GS; Ziegler TR
Nutrition; 2017 Jun; 38():102-108. PubMed ID: 28526374
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial.
Meireles MS; Kamimura MA; Dalboni MA; Giffoni de Carvalho JT; Aoike DT; Cuppari L
Clin Nutr; 2016 Dec; 35(6):1251-1258. PubMed ID: 27161894
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation reduces insulin resistance in Japanese adults: a secondary analysis of a double-blind, randomized, placebo-controlled trial.
Sun X; Cao ZB; Tanisawa K; Ito T; Oshima S; Higuchi M
Nutr Res; 2016 Oct; 36(10):1121-1129. PubMed ID: 27865354
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
[TBL] [Abstract][Full Text] [Related]
14. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study.
Wagner CL; Hulsey TC; Fanning D; Ebeling M; Hollis BW
Breastfeed Med; 2006; 1(2):59-70. PubMed ID: 17661565
[TBL] [Abstract][Full Text] [Related]
15. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
Li WZ; Wang XY; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):466-8. PubMed ID: 19304526
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression.
Thill M; Woeste A; Reichert K; Fischer D; Rody A; Friedrich M; Köster F
Anticancer Res; 2015 Feb; 35(2):1197-203. PubMed ID: 25667511
[TBL] [Abstract][Full Text] [Related]
17. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial.
Gallo S; Comeau K; Vanstone C; Agellon S; Sharma A; Jones G; L'Abbé M; Khamessan A; Rodd C; Weiler H
JAMA; 2013 May; 309(17):1785-92. PubMed ID: 23632722
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain.
Gendelman O; Itzhaki D; Makarov S; Bennun M; Amital H
Lupus; 2015 Apr; 24(4-5):483-9. PubMed ID: 25801891
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
